4-(5-(5-HYDROXY-3-PHENYL-4-ISOXAZOLYL)-2,4-PENTADIEN-1-YLIDENE)-3-PHENYL-5(4H)-ISOXAZOLONE
UNII 5MBE8Z16VP
Substance Identification & Data
This profile provides standardized clinical and technical data for 4-(5-(5-hydroxy-3-phenyl-4-isoxazolyl)-2,4-pentadien-1-ylidene)-3-phenyl-5(4h)-isoxazolone, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 5MBE8Z16VP.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 61389-30-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C23H16N2O4 NEDZCQDBZLHEGJ-UFRBDIPQSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 4-(5-(5-hydroxy-3-phenyl-4-isoxazolyl)-2,4-pentadien-1-ylidene)-3-phenyl-5(4h)-isoxazolone. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.